Skip to main content
. 2016 May 18;78:91–99. doi: 10.1007/s00280-016-3062-2

Table 2.

Adverse events during the treatment period (n = 33)

Grade
1 2 3 4 All, % 3/4, %
Adverse events during induction chemotherapy
Hematologic
 Leukopenia 5 15 11 2 100 39
 Neutropenia 0 9 12 12 100 72
 Anemia 22 11 0 0 100 0
 Thrombocytopenia 22 11 0 0 100 0
Non-hematologic
 Creatinine increased 7 0 0 0 21 0
 Elevation of AST 14 0 0 0 42 0
 Elevation of ALT 10 9 1 0 30 3
 Febrile neutropenia 1 1 6 6
 Hyperbilirubinemia 3 1 0 0 12 0
 Hyponatremia (≥G3) 1 1 6 6
 Alopecia 14 6 0 0 60 0
 Anorexia 10 13 6 0 87 18
 Constipation 8 6 0 0 42 0
 Diarrhea 9 3 0 0 38 0
 Dysphagia 7 6 4 0 51 12
 Edema 2 0 1 0 9 3
 Fever 2 0 1 0 9 3
 Fistula GI-esophagus 0 0 1 0 3 3
 Infection with normal ANC 0 0 1 1 6 6
 Nausea 13 7 3 0 69 9
 Rash 3 0 0 0 9 0
 Stomatitis 11 6 1 0 54 3
 Vomiting 3 2 0 0 15 0
Adverse events during chemoradiation
Hematologic
 Leukopenia 5 15 8 0 85 24
 Neutropenia 11 10 6 0 82 18
 Anemia 6 22 1 0 88 3
 Thrombocytopenia 9 2 0 0 33 0
Non-hematologic
 Creatinine increased 8 1 0 0 27 0
 Elevation of AST 5 0 0 0 15 0
 Elevation of ALT 0 7 0 0 21 0
 Febrile neutropenia 1 0 3 3
 Alopecia 14 8 0 0 67 0
 Anorexia 12 6 4 0 67 12
 Constipation 9 0 0 0 27 0
 Diarrhea 4 0 0 0 12 0
 Dysphagia 8 8 5 0 64 15
 Edema 1 1 0 0 6 0
 Esophagitis (≥G3) 4 0 12
 Fever 2 0 0 0 6 0
 Fistula GI-esophagus 0 0 1 0 3 3
 Infection with normal ANC 1 0 1 0 6 3
 Nausea 12 3 3 0 55 9
 Neuropathy sensory 2 0 0 0 6 0
 Stomatitis 4 0 0 0 12 0
 Vomiting 3 1 0 0 12 0